期刊文献+

骨代谢标志物在恶性肿瘤骨转移诊治中的应用 被引量:2

Clinical application of markers of bone metabolism in patients with bone metastases
原文传递
导出
摘要 骨是晚期恶性肿瘤最常见的转移部位之一。在正常情况下,骨重建是一个平衡的过程,是破骨细胞不断吸收旧骨和成骨细胞不断形成新骨的过程。当恶性肿瘤发生骨转移时,骨转移灶的骨代谢失去平衡。骨代谢标志物已被证实能反映肿瘤导致的骨代谢的变化。本文就骨代谢标志物在骨转移瘤早期诊断、病情判断、疗效监测及预后评估等方面的应用进行综述,以探讨它们的临床应用价值。 Bone metastases are frequent and seen in many malignancies.Under normal conditions,the bone remodelling process is a balanced,lifelong continuum of resorbing old bone and replacing the removed tissue by an equal amount of newly formed bone.The presence of bone metastases greatly perturbs the balance of normal bone remodeling.Biochemical markers of bone metabolism have been shown to reflect these tumor-induced changes in bone remodeling.This review summarized the available evidence on the clinical application of bone metabolism markers in diagnostic,prognostic,and monitoring purposes for patients with bone metastases.
作者 潘兴喜 杨文
出处 《中华临床医师杂志(电子版)》 CAS 2017年第8期1388-1391,共4页 Chinese Journal of Clinicians(Electronic Edition)
基金 广东省佛山市医学类科技攻关项目(201308168)
关键词 骨代谢标志物 骨转移 诊断 预后 】 Biochemical markers of bone metabolism Bone metastases Diagnosis Prognosis
  • 相关文献

参考文献5

二级参考文献49

  • 1Claire B. POLLOCK,Kathleen KELLY.Mechanisms of cancer metastasis to the bone[J].Cell Research,2005,15(1):57-62. 被引量:55
  • 2Maeda H, Koizumi M, Yoshimura K, et al. Correlation between bone metabolic markers and bone scan in prostatic cancer. J Urol, 1997,157:539-543.
  • 3Garnero P, Ferreras M, Karsdal M A, et al. The type I collagen f ragments ICTP and CTx reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Re, 2003,18:859-867.
  • 4Koizumi M, Ogata E. Bone metabolic markers as gauges of metastasis to bone :a review. Ann Nucl Med, 2002,16:161-168.
  • 5Gianini B, Mario JM, Laird M, et al. Urinary hydroxyproline and calcium metabolism in patients with cancer. N Engl JMed, 1996,275:298-302.
  • 6Delmas PD, Wahner HW, Mann KG, et al. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Glaprotein. J Lab Clin Med, 1983,102: 470.
  • 7Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity [J]. Clin Cancer Res, 2006, 12:6243 - 6249.
  • 8江泽飞,于世英,孙燕.恶性肿瘤骨转移及骨相关疾病临床诊疗专家共识(20LO年版)[M].北京;北京大学医学出版社,2010,47-55.
  • 9Catherine H, Van Poznak, Sarah Temin, et al. American so- ciety of clinical oneology executive summary of the clinical practice guideline update on the role of bone - modifying a- gents in metastatic breast cancer[ J]. J Clin Oncol,2011,29 (9) :1221 - 1227.
  • 10Fizazi K, Lipton A, Mariette X. et al. Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after in- travenous bisphosphonates [J]. J Clin Oncol, 2009, 27 (10) : 1564 - 1571.

共引文献26

同被引文献30

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部